Target intelligence / Profile preview

Plexin-A2 receptor (PLXNA2)

Target
PLXNA2
Molecular classification
Receptor, Semaphorin receptor, Single-pass transmembrane protein
01

Overview

Plexin-A2 receptor (PLXNA2) is a single-pass transmembrane protein and a member of the plexin-A family, which acts as a co-receptor for specific semaphorins (notably SEMA3A, SEMA6A/B, and SEMA3C) and mediates axon repulsion and guidance during nervous system development[1][2][6]. By transducing semaphorin signals—often with neuropilin co-receptors—Plexin-A2 triggers cytoskeletal remodeling, directing neuron migration and networking. It plays critical roles in central nervous system development, cell migration, and, importantly, has been shown to promote cell proliferation and tumor growth (notably in glioblastoma)[3][7][8]. Mutations or abnormal expression of PLXNA2 are implicated in various neurological and developmental disorders, including intellectual disability, schizophrenia, and certain congenital anomalies[1][2]. High expression correlates with poor prognosis in some cancers, suggesting therapeutic relevance and potential as an anti-tumorigenic target[3].

Other names
Plexin-A2PLXNA2KIAA0463OCTPLXN2UNQ209/PRO235FLJ11751FLJ30634Semaphorin receptor OCTplexin 2transmembrane protein OCT
02

Mechanism of action

Modulation of semaphorin interaction and downstream signaling; Regulation of cell proliferation pathways (e.g., via FARP2, FYN, AKT, and p38MAPK)

03

Biological functions

Signal transductionAxon guidanceCell migrationCytoskeletal remodelingCell proliferation
04

Disease associations

CancerIntellectual disabilitySchizophreniaCongenital heart diseaseLoeys-Dietz syndromeAnxiety disorders
05

Safety considerations

Potential off-target effects due to plexin family redundancyContext-dependent effects in tumors based on p53 status

Beyond the preview

Go deeper on Plexin-A2 receptor (PLXNA2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Plexin-A2 receptor (PLXNA2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call